PMID- 1968926 OWN - NLM STAT- MEDLINE DCOM- 19900416 LR - 20171116 IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 144 IP - 6 DP - 1990 Mar 15 TI - Interactions between a lymphoma membrane-associated guanosine 5'-triphosphate-binding protein and the cytoskeleton during receptor patching and capping. PG - 2242-52 AB - In this study we have used several complementary techniques to isolate and characterize a lymphoma membrane-associated 41-kDa protein that shares a number of structural and functional similarities with the alpha i subunit of the guanosine 5'-triphosphate (GTP)-binding protein (e.g., Gi alpha-like protein). In addition, using permeabilized lymphoma cells, we have found that: 1) GTP or GTP-tau-S augments, and pertussis toxin inhibits, phospholipase C (PLC) activity and receptor capping; and 2) the addition of lymphoma 41-kDa Gi alpha-like protein stimulates PLC activity and receptor patching/capping, and reverses the inhibitory effect of pertussis toxin on both activity and receptor patching/capping. Additional cytochemical and biochemical data indicate that the lymphoma 41-kDa protein is closely associated with several cytoskeletal proteins (e.g., actin, myosin, and fodrin) all of which colocalize under receptor cap structures. Furthermore, both the 41-kDa-mediated phospholipase C activity and receptor patching/capping are inhibited by cytochalasin D (a microfilament disrupting drug) and W-7 drug (a calmodulin inhibitor). Together, these data provide strong evidence for a functional association between the lymphoma membrane cytoskeleton and the 41-kDa (Gi alpha-like) protein. Specifically, this association appears to be required for the activation of phospholipase C that results in inositol triphosphate production, subsequent internal Ca2+ release, and finally surface receptor patching and capping. FAU - Bourguignon, L Y AU - Bourguignon LY AD - Department of Cell Biology and Anatomy, School of Medicine, University of Miami, FL 33101. FAU - Walker, G AU - Walker G FAU - Huang, H S AU - Huang HS LA - eng GR - GM 36353/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Antigens, Surface) RN - 0 (Membrane Proteins) RN - 0 (Sulfonamides) RN - 0 (Thy-1 Antigens) RN - 0 (Virulence Factors, Bordetella) RN - 22144-77-0 (Cytochalasin D) RN - 65595-90-6 (W 7) RN - 86-01-1 (Guanosine Triphosphate) RN - EC 2.4.2.31 (Pertussis Toxin) RN - EC 3.1.4.- (Type C Phospholipases) RN - EC 3.6.1.- (GTP-Binding Proteins) SB - IM MH - Animals MH - Antigens, Surface/metabolism MH - Cell Line MH - Cytochalasin D/pharmacology MH - Cytoskeleton/*metabolism MH - GTP-Binding Proteins/*metabolism MH - Guanosine Triphosphate/pharmacology MH - *Immunologic Capping/drug effects MH - Lymphoma/*metabolism MH - Membrane Proteins/metabolism MH - Mice MH - Molecular Weight MH - Peptide Mapping MH - Pertussis Toxin MH - *Receptor Aggregation/drug effects MH - Sulfonamides/pharmacology MH - Thy-1 Antigens MH - Tumor Cells, Cultured MH - Type C Phospholipases/metabolism MH - Virulence Factors, Bordetella/pharmacology EDAT- 1990/03/15 00:00 MHDA- 1990/03/15 00:01 CRDT- 1990/03/15 00:00 PHST- 1990/03/15 00:00 [pubmed] PHST- 1990/03/15 00:01 [medline] PHST- 1990/03/15 00:00 [entrez] PST - ppublish SO - J Immunol. 1990 Mar 15;144(6):2242-52.